Skip to main content
. 2021 Aug 5;2021(8):CD012548. doi: 10.1002/14651858.CD012548.pub2

2.1. Analysis.

2.1

Comparison 2: Degarelix versus androgen suppression therapy (GnRH agonists or maximum androgen suppression therapy): subgroup analysis based on different doses, Outcome 1: Serious adverse events